ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,122Medicare Part D Prescriptions Filled, Including Refills

Rank: 156 out of 1269

$359K Total Retail Price of All Prescriptions

Rank: 287 out of 1269

484 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
4% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 484 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

12% of this provider’s 484 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

0% of this provider’s 6,988 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
HYDROCHLOROTHIAZIDE 433 426 1 10
LOSARTAN POTASSIUM 384 378 2 15
LOVASTATIN 370 364 3 30
ATENOLOL 339 333 4 14
AMLODIPINE BESYLATE 334 330 5 2
LISINOPRIL 305 292 6 1
SIMVASTATIN 288 273 7 3
OMEPRAZOLE 242 238 8 8
LEVOTHROID 216 214 9 90
ENALAPRIL MALEATE 193 193 10 79
LEVOTHYROXINE SODIUM 171 166 11 4
FUROSEMIDE 142 141 12 5
GABAPENTIN 141 137 13 17
ADACEL 135 134 14 177
PRAVASTATIN SODIUM 130 130 15 11
HYDROCODONE-ACETAMINOPHEN 121 120 S3 16 20
WARFARIN SODIUM 120 120 17 12
METOPROLOL TARTRATE 113 113 18 6
INSULIN SYRINGE 109 109 19 87
METFORMIN HCL 107 103 20 9
ALENDRONATE SODIUM 107 105 20 28
NOVOLIN N 98 97 22 124
ATORVASTATIN CALCIUM 95 95 23 7
PANTOPRAZOLE SODIUM 77 77 24 18
GLIPIZIDE 68 65 25 37
FLUTICASONE PROPIONATE 67 65 26 40
DILTIAZEM ER 62 62 27 352
QVAR 61 60 28 260
K-TAB 58 58 29 159
TRAMADOL HCL 52 52 30 16
ZOLPIDEM TARTRATE 52 51 30 19
PROAIR HFA 50 48 32 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 16, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.